Search
Close this search box.

Watch Now: NIH ME/CFS Research Roadmap Webinar Series Recordings

The ME/CFS Research Roadmap webinars, hosted by the National Institute of Health (NIH), have successfully concluded. These virtual events brought together ME/CFS experts to present current research, identify knowledge gaps, and explore future research opportunities for ME/CFS. 

 

Open Medicine Foundation proudly participated in these webinars, with our team members not only contributing as presenters and moderators, but also driving the conversation forward in the quest for understanding ME/CFS.

Overview of webinar topics and images of David Systrom presenting and Linda Tannenbaum networking at the Open Medicine Foundation table.

Webinar on the Nervous System and ME/CFS, August 25, 2023 

  • Jonas Bergquist, MD, PhD, OMF Chief Medical Officer and Director of the OMF supported ME/CFS Collaborative Research Center at Uppsala University, presented on “Cerebral Spinal Fluid Studies.”

Webinar on Immune System and ME/CFS, October 19, 2023

  • Maureen Hanson, PhD, Cornell University & OMF Scientific Advisory Board Member, presented on “Immune cell-type approaches to identify mechanisms of ME/CFS.”

Webinar on Metabolism and ME/CFS, October 26, 2023 

  • Alain Moreau, PhD, Director of the OMF supported ME/CFS Collaborative Research Center at the University of Montreal, was the moderator. 
  • Wenzhong Xiao, PhD, Director of the OMF supported ME/CFS Collaborative Research Center at Harvard, presented on “Studying Metabolomics in ME/CFS – A Computational Perspective.”
  • Christopher W. Armstrong, PhD, Director of the OMF supported ME/CFS Collaborative Research Center at Melbourne, presented on “Metabolic characterisation of biofluids in ME/CFS.”

Webinar on Genomics/Genetic Susceptibilities, November 1, 2023 

  • David Systrom, MD, Director of the OMF supported ME/CFS Collaborative Research Center at Harvard, was the moderator. 
  • Alain Moreau, PhD, Director of the OMF supported ME/CFS Collaborative Research Center at the University of Montreal, presented on “Contribution of Epigenomics to ME/CFS Pathogenesis: Past, Present and Future.” 
  • Fereshteh Jahaniani, PhD, Stanford, presented on “Characterizing the Genetic Basis of ME/CFS through Case-Control and Family Studies.”

Webinar on Chronic Infections, November 30, 2023

  • Maureen Hanson, PhD; Cornell University & OMF Scientific Advisory Board Member, presented on “Chronic infection in ME/CFS: non-Herpes viruses.”

Webinar on Physiology, December 8, 2023

  • Robert Naviaux, MD, PhD; University of California & OMF Scientific Advisory Board Member, presented on “The Cell Danger Response.”
  • Robert Phair, PhD, presented on “Update on the Itaconate Shunt Hypothesis.”
  • Ron Davis, PhD, Director of the OMF supported ME/CFS Collaborative Research Center at Stanford University & OMF Scientific Advisory Board Director, presented on “BH4: a potential culprit.”

Webinar on Advancing ME/CFS Research: Identifying Targets for Intervention and Learning from Long COVID, December 12, 2023

  • Mark M. Davis, PhD, Stanford University & OMF Scientific Advisory Board Member, presented on “Oxidative stress is a shared characteristic of both ME-CFS and Long Covid.”
  • David Systrom, MD, Director of the OMF supported ME/CFS Collaborative Research Center at Harvard, presented on “Neurovascular dysregulation during exercise in ME/CFS.”

Webinar on Advancing ME/CFS Research: Identifying Targets for Intervention and Learning from Long COVID, December 13, 2023

  • Alain Moreau, PhD, Director of the OMF supported ME/CFS Collaborative Research Center at the University of Montreal, was the moderator. 
  • Lucinda Bateman, MD, Founder and Medical Director of Bateman Horne Center & OMF Scientific Advisory Board Member, presented on: “Using RECOVER to Understand ME/CFS and Long COVID.”
  • Maureen Hanson, PhD, Cornell University & OMF Scientific Advisory Board Member, presented on: “ME/CFS and Long COVID: Similarities and Differences.”
  • Alain Moreau, PhD, Director of the OMF supported ME/CFS Collaborative Research Center at the University of Montreal, presented on “Contribution of Epigenetics in ME/CFS and Long COVID Pathogenesis.”

Webinar on Lesser Studied Pathologies, January 5, 2024

 

Webinar on Circulation, January 11, 2024

  • David Systrom, MD, Director of the OMF supported ME/CFS Collaborative Research Center at Harvard, presented on “Neurovascular Dysregulation.”



The progress in ME/CFS research is a direct result of the support from our community. Your generosity fuels further discoveries and brings us closer to finding effective treatments. Please consider making a donation to help sustain and accelerate this important work.  

We thank you for your continued support and for being an integral part of our mission. 



Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669